Early improvement as a predictor of later response to lurasidone in schizophrenia from Japan trials: A diagnostic test
Sign Up to like & getrecommendations! Published in 2022 at "Psychiatry and Clinical Neurosciences"
DOI: 10.1111/pcn.13377
Abstract: A recent 6-week, double-blind, randomized, placebo-controlled trial on lurasidone for acute schizophrenia in Japan 1 demonstrated that lurasidone (LUR) 40 mg/day (LUR40) improved Positive and Negative Syndrome Scale (PANSS) 2 total score (PANSS-T) while being… read more here.
Keywords: japan trials; schizophrenia; lurasidone; panss ... See more keywords